col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Autoimmunity Reviews
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―10 The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases Luis J. Jara, Berenice López-Zamora, Irvin Ordoñez-González, María F. Galaviz-Sánchez, Caroline I. Gutiérrez-Melgarejo, Miguel A. Saavedra, et al. (+3)
2 [GO] 2021―Sep―09 Autoimmunity roots of the thrombotic events after COVID-19 vaccination Fatma Elrashdy, Murtaza M. Tambuwala, Sk. Sarif Hassan, Parise Adadi, Murat Seyran, Tarek Mohamed Abd El-Aziz, et al. (+19)
3 [GO] 2021―Sep―09 IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19 Laure Badier, Albanie Toledano, Tiphaine Porel, Sylvain Dumond, Julien Jouglen, Laurent Sailler, et al. (+3)
4 [GO] 2021―Aug―30 Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis Anuraag Jena, Shubhra Mishra, Parakkal Deepak, Praveen Kumar-M, Aman Sharma, Yusuf I. Patel, et al. (+4)
5 [GO] 2021―Jul―22 Antiphospholipid antibodies and COVID-19 Antonio La Cava
6 [GO] 2021―Jul―16 The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19 Elrashdy M. Redwan, Mohammed F. Alghamdi, Tarek Mohamed Abd El-Aziz, Parise Adadi, Alaa A.A. Aljabali, Diksha Attrish, et al. (+23)
7 [GO] 2021―Jul―15 Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma Marco Matucci Cerinic, Michael Hughes, Gloria Taliani, Bashar Kahaleh
8 [GO] 2021―Jul―03 COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? Abdorreza Naser Moghadasi
9 [GO] 2021―Jun―10 Autoimmunity and COVID-19 - The microbiotal connection Nurit Katz-Agranov, Gisele Zandman-Goddard
10 [GO] 2021―Jun―10 Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review Mayka Freire, Ariadna Andrade, Bernardo Sopeña, Maria Lopez-Rodriguez, Pablo Varela, Purificación Cacabelos, et al. (+2)
11 [GO] 2021―May―08 Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19 Ozlem Saritas Nakip, Selman Kesici, Benan Bayrakci
12 [GO] 2021―Apr―19 Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent Olivier Vollmer, Charles Tacquard, Yannick Dieudonné, Benoit Nespola, Laurent Sattler, Lélia Grunebaum, et al. (+14)
13 [GO] 2021―Mar―18 A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis Abdorreza Naser Moghadasi
14 [GO] 2021―Feb―21 Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data Chuanhui Xu, Zixi Yi, Ruyi Cai, Ru Chen, Bernard Yu-Hor Thong, Rong Mu
15 [GO] 2021―Feb―21 Molecular mimicry between SARS-CoV-2 and human proteins Yekbun Adiguzel
16 [GO] 2021―Feb―21 The SARS-CoV-2 as an instrumental trigger of autoimmunity Arad Dotan, Sylviane Muller, Darja Kanduc, Paula David, Gilad Halpert, Yehuda Shoenfeld
17 [GO] 2021―Jan―18 Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement Shaghayegh Shahmirzaei, Abdorreza Naser Moghadasi
18 [GO] 2021―Jan―18 Autoantibodies in COVID-19: frequency and function Zhao-wei Gao, Hui-zhong Zhang, Chong Liu, Ke Dong
19 [GO] 2020―Dec―15 Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valery Blasco, Julien Carvelli, David Delarbre, et al. (+3)
20 [GO] 2020―Dec―13 Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward Alexandre Le Joncour, Corinne Frere, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, Georgina Maalouf, et al. (+7)
21 [GO] 2020―Oct―28 SARS-CoV-2, the autoimmune virus Gilad Halpert, Yehuda Shoenfeld
22 [GO] 2020―Oct―27 COVID-19 and Immune-Mediated Inflammatory Diseases: Why don't our patients get worse? Víctor M. Martínez-Taboada, Marcos López-Hoyos, Javier Crespo, José L. Hernández
23 [GO] 2020―Oct―22 Guillian Barré syndrome and COVID-19: Possible role of the cytokine storm Faraz S. Hussain, Mohamed A. Eldeeb, Derrick Blackmore, Zaeem A. Siddiqi
24 [GO] 2020―Sep―14 Screening neuromyelitis optica patients for COVID-19 infection Omid Mirmosayyeb, Saeed Vaheb, Mahdi Barzegar, Vahid Shaygannejad, Simona Bonavita, Mahsa Ghajarzadeh
25 [GO] 2020―Sep―14 What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese
26 [GO] 2020―Aug―13 Risk of COVID-19 in celiac disease patients Fabiana Zingone, Anna D'Odorico, Greta Lorenzon, Ilaria Marsilio, Fabio Farinati, Edoardo Vincenzo Savarino
27 [GO] 2020―Jun―11 Molecular mimicry may explain multi-organ damage in COVID-19 Francesca Angileri, Sébastien Legare, Antonella Marino Gammazza, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello
28 [GO] 2020―Jun―11 Covid-19 and autoimmunity Michael Ehrenfeld, Angela Tincani, Laura Andreoli, Marco Cattalini, Assaf Greenbaum, Darja Kanduc, et al. (+5)
29 [GO] 2020―May―05 Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? Nicoletta Del Papa, Gianluca Sambataro, Antonina Minniti, Francesca Pignataro, Roberto Caporali
30 [GO] 2020―May―05 How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion Piercarlo Sarzi-Puttini, Daniela Marotto, Marco Antivalle, Fausto Salaffi, Fabiola Atzeni, Giovanni Maconi, et al. (+5)
31 [GO] 2020―May―05 COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Serena Colafrancesco, Cristiano Alessandri, Fabrizio Conti, Roberta Priori
32 [GO] 2020―May―05 Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection Louise Cunningham, Ian Kimber, David Arthur Basketter, John Paul McFadden
33 [GO] 2020―May―05 Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Spinello Antinori, Cecilia Bonazzetti, Guido Gubertini, Amedeo Capetti, Cristina Pagani, Valentina Morena, et al. (+4)
34 [GO] 2020―May―05 Convalescent plasma in Covid-19: Possible mechanisms of action Manuel Rojas, Yhojan Rodriguez, Diana M. Monsalve, Yeny Acosta-Ampudia, Bernardo Camacho, Juan Esteban Gallo, et al. (+7)
35 [GO] 2020―May―05 SARS-CoV-2 infection among patients with systemic autoimmune diseases Giacomo Emmi, Alessandra Bettiol, Irene Mattioli, Elena Silvestri, Gerardo Di Scala, Maria Letizia Urban, et al. (+2)
36 [GO] 2020―May―05 Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis Omer Gendelman, Howard Amital, Nicola Luigi Bragazzi, Abdulla Watad, Gabriel Chodick
37 [GO] 2020―May―04 Imatinib might constitute a treatment option for lung involvement in COVID-19 David Bernal-Bello, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega, José Manuel Ruiz-Giardin, Virginia García-Bermúdez, Begoña Frutos-Pérez, et al. (+6)
38 [GO] 2020―May―04 Cytokine storm syndrome in severe COVID-19 Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, Roberto Giacomelli
39 [GO] 2020―May―04 Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review Jaume Alijotas-Reig, Enrique Esteve-Valverde, Cristina Belizna, Albert Selva-O'Callaghan, Josep Pardos-Gea, Angela Quintana, et al. (+3)
40 [GO] 2020―May―04 Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view Andreas Kronbichler, Maria Effenberger, Michael Eisenhut, Keum Hwa Lee, Jae Il Shin
41 [GO] 2020―May―04 Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy Paola Toniati, Simone Piva, Marco Cattalini, Emirena Garrafa, Francesca Regola, Francesco Castelli, et al. (+4)
42 [GO] 2020―May―04 Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms Federica Raucci, Adel Abo Mansour, Gian Marco Casillo, Anella Saviano, Francesco Caso, Raffaele Scarpa, et al. (+3)
43 [GO] 2020―May―04 Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, et al. (+3)
44 [GO] 2020―May―03 Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? Mohammed S. Osman, Charmaine van Eeden, Jan Willem Cohen Tervaert
45 [GO] 2020―May―03 Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies Paolo Fagone, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, et al. (+3)
46 [GO] 2020―May―01 Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood
47 [GO] 2020―May―01 Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons Guglielmo Lucchese, Agnes Flöel
48 [GO] 2020―May―01 The correlation between SARS-CoV-2 infection and rheumatic disease Zhao-wei Gao, Xi Wang, Fang Lin, Ke Dong
49 [GO] 2020―May―01 SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
50 [GO] 2020―Apr―05 Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning Yehuda Shoenfeld
51 [GO] 2020―Apr―04 ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia Felice Rivellese, Edoardo Prediletto
52 [GO] 2020―Apr―04 The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood
53 [GO] 2020―Apr―03 What is the role of rheumatologists in the era of COVID-19? Daniela Marotto, Piercarlo Sarzi-Puttini
54 [GO] 2020―Mar―20 COVID-19 infection and rheumatoid arthritis: Faraway, so close! Ennio Giulio Favalli, Francesca Ingegnoli, Orazio De Lucia, Gilberto Cincinelli, Rolando Cimaz, Roberto Caporali


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec